Tygacil FDA Approval History
FDA Approved: Yes (First approved June 15, 2005)
Brand name: Tygacil
Generic name: tigecycline
Dosage form: Injection
Company: Wyeth Pharmaceuticals
Treatment for: Skin and Structure Infection, Intraabdominal Infection, Pneumonia
Tygacil (tigecycline) is a glycylcycline antibacterial indicated for the treatment of complicated skin and skin structure infections, complicated intra-abdominal infections and community-acquired bacterial pneumonia in adults.
Development timeline for Tygacil
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.